Artikel ; Online: Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis.
2017 Band 18, Heft 14, Seite(n) 1598–1621
Abstract: Background: Parasitic infection such as leishmaniasis, a neglected tropical disease, presents a significant global burden which is responsible for high mortality rate especially in less developed countries. Its intracellular nature and disseminated ... ...
| Abstract | Background: Parasitic infection such as leishmaniasis, a neglected tropical disease, presents a significant global burden which is responsible for high mortality rate especially in less developed countries. Its intracellular nature and disseminated locations of parasite, limited number of chemotherapeutic agents, increasing incidences of resistance to first line drugs and toxicities, pose a great challenge to formulation scientists that have necessitated effective management of leishmanial infection by modulating the delivery of existing drugs. Over the past decade, research on development of alternative treatments such as nanotechnology-based drug delivery systems (nanoparticles, nanosuspensions, liposomes etc.), use of natural products as well as development of antileishmanial vaccine has been extensively investigated. Objective: The present review focuses on different facets of therapeutic strategies, existing miscellaneous drug delivery systems and approaches intended for management, as well as treatment of the infection, with an objective to summarize the current trends and strategies adopted for antileishmanial therapy in a systematic manner. Moreover, the article encloses an eclectic collection of patents allied to new-fangled chemotherapeutics for antileishmanial therapy. Conclusion: The reported miscellaneous novel drug delivery systems along with the diverse approaches are seem to be precise, secure and relatively effective; and in an outcome, could lead to the new track for management of leishmaniasis. |
|---|---|
| Mesh-Begriff(e) | Antiprotozoal Agents/administration & dosage ; Antiprotozoal Agents/therapeutic use ; Drug Carriers/chemistry ; Drug Delivery Systems/trends ; Humans ; Leishmania/drug effects ; Leishmania/metabolism ; Leishmaniasis/drug therapy ; Leishmaniasis/parasitology ; Nanostructures/chemistry ; Neglected Diseases/drug therapy ; Reactive Oxygen Species/metabolism |
| Chemische Substanzen | Antiprotozoal Agents ; Drug Carriers ; Reactive Oxygen Species |
| Sprache | Englisch |
| Erscheinungsdatum | 2017 |
| Erscheinungsland | United Arab Emirates |
| Dokumenttyp | Journal Article ; Review |
| ZDB-ID | 2064859-5 |
| ISSN | 1873-5592 ; 1389-4501 |
| ISSN (online) | 1873-5592 |
| ISSN | 1389-4501 |
| DOI | 10.2174/1389450117666160401124133 |
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
| Zs.A 5578: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.